Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HighCycle: Acetazolamide for Pulmonary Artery Pressure at High Altitude
NCT06498505Phase 4Completed
- Sponsor
- University of Zurich
- Start
- Jul 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetazolamide in Altitude sickness (AMS), sponsored by University of Zurich. Started Jul 2024; status: completed.
02
Drugs
acetazolamide
03
Conditions
Altitude sickness (AMS)
Beyond the preview
Go deeper on NCT06498505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06498505.